Past, Present, and Future of BCR-Abl Inhibitors: From Chemical Development to Clinical Efficacy

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-018-0624-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Green Corrosion Inhibitors, Past, Present, and Future

2018English

Adherence to BCR-ABL Inhibitors: Issues for CML Therapy

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2012English

Management of Chronic Myeloid Leukemia With BCR/ABL Inhibitors: Current Status and Future Perspectives

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Broad Spectrum Alkynyl Inhibitors of T315I BCR-Abl

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2010English

Clinical Pharmacology in Japan: Past, Present and Future

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2010English

China’s International Development Finance: Past, Present, and Future

WIDER Working Paper
2015English

Curriculum Development in Science - Past, Present and Future

LUMAT
Education
2015English

Development of Leishmania Vaccines: Predicting the Future From Past and Present Experience

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2013English

Past, Present and Future

Breathe
PulmonaryRespiratory Medicine
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy